Managers / Q2 2021 · view latest →
Meritech Capital Associates V L.L.C.
CIK 0001613048 · 245 LYTTON AVE, SUITE 125, PALO ALTO, CA, 94301 · 650-475-2200
Summary
Meritech Capital Associates V L.L.C. reported $4.7B in U.S.-listed holdings across 4 positions for Q2 2021.
The portfolio is heavily concentrated: RBLX alone accounts for 70.5% of reported value.
Compared with Q1 2021, the fund opened 1 new position and exited 0.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 100.0% · $4.7B
Quarter-over-Quarter Changes full breakdown →
vs Q1 2021 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| OKTAOkta, Inc | NEW | +914.1K | 914.1K | +$224M | $224M |
| RBLXRoblox Corporation | TRIMMED | −9.16M | 36.64M | +$328M | $3.3B |
| TXG10x Genomics, Inc. | TRIMMED | −329.5K | 1.79M | −$33M | $351M |
| DDOGDatadog, Inc | TRIMMED | −647.1K | 7.73M | +$106M | $805M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2021
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | RBLXRoblox Corporationhistory → | Class A Common | 70.50% | $3.3B | 36.64M |
| 2 | DDOGDatadog, Inchistory → | Class A Common | 17.21% | $805M | 7.73M |
| 3 | TXG10x Genomics, Inc.history → | Class A Common | 7.51% | $351M | 1.79M |
| 4 | OKTAOkta, Inchistory → | Class A Common | 4.78% | $224M | 914.1K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $141M | 2 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $180M | 2 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $283M | 2 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $239M | 2 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $156M | 2 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $259M | 2 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $299M | 2 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $292M | 3 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $299M | 3 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $411M | 6 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $314M | 6 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $418M | 6 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $476M | 7 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $410M | 7 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $586M | 7 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $646M | 7 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $1.1B | 6 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $3.1B | 5 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $3.3B | 5 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $4.7B | 4 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $4.1B | 3 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $1.2B | 2 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.